Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;315(10):2921-2926.
doi: 10.1007/s00403-022-02386-4. Epub 2022 Aug 12.

Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance

Affiliations

Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance

Stefan Tukaj et al. Arch Dermatol Res. 2023 Dec.

Abstract

Autoimmune bullous disease autoantibodies, particularly including bullous pemphigoid (BP)-related anti-BP180-NC16A IgG, have been reported in a small subset of healthy individuals, but information about associated factors is lacking. We hypothesized that an abnormal status of immunomodulatory vitamin D could play a role in anti-BP180-NC16A autoantibody reactivity in healthy persons. In addition, we aimed to evaluate the cytokine profile associated with these autoantibodies. Plasma samples from 34 anti-BP180-NC16A IgG-reactive and 85 anti-BP180-NC16A IgG-negative healthy blood donors were tested for levels of 25-hydroxyvitamin D [25(OH)D] and a wide range of cytokines (IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, IL-17A, IL-17F, IL-21, IL-22, IFN-γ, and TNF-α). We observed that anti-BP180-NC16A IgG-reactive healthy subjects had significantly lower plasma 25(OH)D levels and about a two-fold higher rate of vitamin D deficiency (< 20 ng/ml) compared to anti-BP180-NC16A IgG-negative healthy persons. In addition, anti-BP180-NC16A IgG-positive samples were characterized by significantly higher levels of IL-2, IL-5, IL-9, IL-10, and IL-13 which were, however, not significantly associated with the vitamin D levels. Our results indicate that healthy individuals with BP autoantibody reactivity share similarities with BP patients regarding the vitamin D status and cytokine profile (i.e., marked hypovitaminosis D and Th2 predominance), which may have pathophysiologic implications.

Keywords: 25(OH)D; Bullous pemphigoid; Cytokine; Th2; Vitamin D.

PubMed Disclaimer

Conflict of interest statement

There are no competing conflicts of interest.

Figures

Fig. 1
Fig. 1
Anti-BP180 autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D. Plasma 25-hydroxyvitamin D [25(OH)D] status of anti-BP180-NC16A IgG-positive (n = 34) and anti-BP180-NC16A IgG-negative (n = 85) healthy individuals measured by enzyme-linked immunosorbent assay. 25(OH)D plasma levels of ≥ 30 ng/ml, 20–29 ng/ml, and < 20 ng/ml were considered sufficient, insufficient, and deficient, respectively. The squares/dots and bars indicate individual and mean (± SEM) values in each group, respectively. *P < 0.05
Fig. 2
Fig. 2
Anti-BP180 autoantibody reactivity in healthy individuals is associated with Th2 predominance. Plasma levels of IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, IL-17A, IL-17F, IL-21, IL-22, IFN-γ, and TNF-α in anti-BP180-NC16A IgG-positive (n = 34) and anti-BP180-NC16A IgG-negative (n = 85) healthy individuals measured by flow cytometry. The squares/dots and bars indicate individual and mean (± SEM) values in each group, respectively. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. ns not significant
Fig. 3
Fig. 3
Hypovitaminosis D is not correlated with the Th2-dominant milieu in anti-BP180-NC16A IgG-positive healthy subjects. Heatmap matrix plot of Spearman’s rank correlation coefficients (r) between plasma levels of 25(OH)D, IL-2, IL-5, IL-9, IL-10, and IL-13 in either anti-BP180-NC16A IgG-negative or anti-BP180-NC16A IgG-positive healthy individuals. R values are presented in boxes and significant correlations are indicated by asterisks. *P < 0.05

Similar articles

Cited by

References

    1. Prüßmann J, Prüßmann W, Recke A, et al. Co-occurrence of autoantibodies in healthy blood donors. Exp Dermatol. 2014;23(7):519–521. doi: 10.1111/exd.12445. - DOI - PubMed
    1. Prüßmann W, Prüßmann J, Koga H, et al. Prevalence of pemphigus and pemphigoid autoantibodies in the general population. Orphanet J Rare Dis. 2015;10:63. doi: 10.1186/s13023-015-0278-x. - DOI - PMC - PubMed
    1. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349(16):1526–1533. doi: 10.1056/NEJMoa021933. - DOI - PubMed
    1. Raneses E, McGinley Simpson M, Rosenberg A, Coffman M, Meyerle J. A retrospective review of autoimmune bullous disease antibody positivity before clinical symptoms. J Am Acad Dermatol. 2022;86(1):237–239. doi: 10.1016/j.jaad.2021.02.003. - DOI - PubMed
    1. Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–332. doi: 10.1016/S0140-6736(12)61140-4. - DOI - PubMed